MassBio Town Hall w/ Special Guest Abbie Celniker, Partner, Third Rock Ventures
September 22, 2020 11:00 AM - 11:30 AM
Webinar, click "live-stream" button to view
Add to Calendar
9/22/2020 11:00:00 AM
9/22/2020 11:30:00 AM
MassBio Town Hall w/ Special Guest Abbie Celniker, Partner, Third Rock Ventures
MassBio’s President & CEO, Bob Coughlin, will host a bi-weekly virtual Town Hall for members, taking place every Tuesday at 11am. This will be an opportunity for our members to ask questions, hear what MassBio is up to, and learn more about the state of the industry amidst the COVID-19 pandemic.
For this week's Town Hall, Bob will be joined by Dr. Abbie Celniker, Partner at Third Rock Ventures, to discuss how startups are faring during the COVID pandemic, the general VC investment climate, and how small biotechs are trying to create a diverse and inclusive culture from the start.
Webinar link will be emailed to participants the day before - you can also access it from the "Live Stream" tab below. This event is for members-only.
NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning. Webinar, click "live-stream" button to view
For this week's Town Hall, Bob will be joined by Dr. Abbie Celniker, Partner at Third Rock Ventures, to discuss how startups are faring during the COVID pandemic, the general VC investment climate, and how small biotechs are trying to create a diverse and inclusive culture from the start.
Webinar link will be emailed to participants the day before - you can also access it from the "Live Stream" tab below. This event is for members-only.
NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning. Webinar, click "live-stream" button to view
Partner | Third Rock Ventures
Abbie has over 30 years of experience in Senior R&D and Executive leadership roles. As partner at Third Rock Ventures, she focuses on the formation, development and strategy of portfolio companies. She has a strong commitment to culture, and prioritizes establishing experienced, diverse teams.
Prior to joining the firm, she served as president and CEO of Eleven Biotherapeutics (now Sesen Bio) since 2011. Previously, Abbie was the president and CEO of Taligen Therapeutics from 2008 to 2011, when Taligen Therapeutics was acquired by Alexion Pharmaceuticals; following the acquisition, she served as Alexion’s executive vice president, translational medicine. She has served as the global head of biologics of Novartis AG, the senior vice president of R&D strategy and operations of Millennium Pharmaceuticals (now Takeda) and the vice president of protein technologies of the Wyeth Research facilities. She is a member of the board of directors of Abata Therapeutics and Flare Therapeutics. She has a B.A. in biology from the University of California, San Diego, and a Ph.D. in molecular biology from the University of Arizona.